港股异动 | 乐普生物-B(02157.HK)涨幅扩大逾12% MRG004A启动III期临床 MRG007完成首例患者入组

智通财经
Aug 05
【港股异动 | 乐普生物-B(02157.HK)涨幅扩大逾12% MRG004A启动III期临床 MRG007完成首例患者入组】智通财经APP获悉,乐普生物-B(02157.HK)尾盘涨幅扩大逾12%,截至发稿,涨12.14%,报9.33港元,成交额4.48亿港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10